AbbVie Announces Significant Dividend Increase for Shareholders
AbbVie’s Quarterly Dividend Declaration
The board of directors of AbbVie Inc. (NYSE: ABBV) has announced a quarterly cash dividend of $1.55 per share. This decision underlines the company's commitment to delivering shareholder value through consistent and robust dividend payouts.
Dividend Details and Schedule
The declared dividend is set to be distributed on November 15, 2024, to stockholders who are on record as of the end of business on October 15, 2024. This schedule ensures that shareholders receive their due dividends in a timely manner.
Impressive Dividend Growth
Since AbbVie’s formation in 2013, the company has impressively increased its dividend by over 285 percent. This remarkable growth places AbbVie among the elite companies on the S&P Dividend Aristocrats Index, which highlights organizations that have consistently raised dividends for at least 25 years. This track record speaks volumes about the company’s financial health and its commitment to rewarding shareholders.
About AbbVie: Innovation and Commitment
AbbVie is dedicated to discovering and providing innovative medications and solutions aimed at addressing serious health issues both today and in the future. The company focuses on making a significant difference in the lives of individuals through various therapeutic areas, including immunology, oncology, neuroscience, and eye care. Their product offering includes an extensive range in the Allergan Aesthetics portfolio, further underscoring their commitment to advancing healthcare.
Connecting with AbbVie
For those interested in learning more about AbbVie’s mission and initiatives, additional information is accessible on their official website. You can also find them on various social media platforms like LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube, where they frequently update their community on new developments and offerings.
Frequently Asked Questions
What is the declared quarterly dividend amount by AbbVie?
The recent quarterly dividend declared by AbbVie is $1.55 per share.
When is the dividend payment date?
AbbVie plans to distribute the declared dividend on November 15, 2024.
What is AbbVie’s history with dividend increases?
Since its inception in 2013, AbbVie has increased its dividend by over 285 percent.
What index is AbbVie a part of due to its dividend performance?
AbbVie is a member of the S&P Dividend Aristocrats Index, which includes companies with a history of raising dividends for at least 25 consecutive years.
How can I connect with AbbVie for more information?
To get more information, you can visit AbbVie’s official website or follow them on social media platforms like LinkedIn and Facebook.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Revolutionizing Financial Services with AI: Insights for Small Banks
- Yardi Forms Alliance with Boundary Stone for Energy Initiatives
- Fuel Management Systems Market Poised for Significant Growth
- Support Grows for Kamala Harris Ahead of Tight Election
- Understanding the Market Trends and Options for Uber (UBER)
- Harnessing Digital Tools for Success in Cannabis Retailing
- New Funding for Indigenous Housing Projects in Ontario
- Stock Performance in the U.K.: A Closer Look at Trends
- Sea Limited Stocks Maintain Strong Position Amid Fee Increases
- Chubb: A Significant Long-Term Investment Journey
Recent Articles
- Scientific Games Launches Urban Farm to Boost Community Health
- Exploring the Future of Coolant Distribution Units Market Growth
- Exploring the Growth of the Blockchain Security Market
- Revolutionary Blood Test for Alzheimer's: A Game Changer
- Sasol Files Annual Report for Financial Year Ending June 2024
- Understanding the Federal Reserve's Economic Data Trends
- FuelCell Energy Reports Q3 Results and Strategic Plans Ahead
- North West Company Navigates Challenges While Driving Growth
- Concerns Grow Over Chinese Drones in U.S. Agriculture Sector
- Social Media's Response to Alleged Foreign Influence in Elections
- Economic Resilience Bolsters Markets Following Payroll Report
- Insights on Unemployment Trends and Federal Reserve Predictions
- Exploring Disney's Musical Journey with New Releases
- Pacsun and Paris Hilton Unveil Exclusive Merchandise Collection
- DEVGRU and Accelalpha Unite to Enhance Customer Experience
- Rainbow Robotics Showcases Innovative Solutions at IMTS 2024
- ReloQuest Unveils RQ VantagePoint: A Game-Changer in Data Access
- SRS Real Estate Partners Strengthens Portfolio in Jacksonville
- Nulogy and Kinaxis Team Up to Transform Supply Chain Dynamics
- TOMI Environmental Solutions Set to Shine at Investor Conference
- Celebrating Innovators: WealthManagement.com's 2024 Awards Results
- Middlefield Canadian Income PCC Shares: Current NAV Update
- Discover the Eureka J15 Pro Ultra: A Revolutionary Robot Vacuum
- Uber Technologies Class Action Settlement Announcement Details
- Body Vision Medical Unveils Advanced Technology at ERS Congress
- August 2024 Hospital PMI® Reports Continued Economic Growth
- BLUETTI AC240P: Revolutionizing Portable Power for Everyone
- Exploring the Growth of Vibration Monitoring Market by 2029
- Urban Logistics Market Set for Rapid Growth to $77 Billion
- US LBM Expands Operations with Nix Door Acquisition
- Kirkland's Fights Through Challenges with Strategic Plans
- Lakeland Industries Reports Positive Revenue Growth Despite Losses
- SecureWorks Reports Strong Q2 FY2025 Results and Growth Prospects
- Japan Inc. Rethinks Foreign Deals After Nippon Steel Setback
- Zumiez Inc. Announces Strong Q2 Performance and Future Plans
- Alimentation Couche-Tard Q1 2025 Report: New CEO Leads Growth
- VersaBank's Expansion into the U.S. Market: A Bright Future
- Analysts Weigh In on Major Drilling's Q1 Financial Performance
- Exciting Developments at Vor Biopharma Inc. and Stock Surge
- Examining Freshpet's Growing Short Interest Phenomenon
- Understanding the Surge in EMCOR Group's Short Interest
- Understanding Mr. Cooper Group's Short Interest Trends
- Understanding Key Market Trends: Insights from Direxion's Ed Egilinsky
- Increased Vyvanse Production: Addressing ADHD Medication Shortages
- Stock Market Overview: US Employment Increase Insight
- American Barbell's Il Padrino: A Game-Changer in Powerlifting
- Elis Explores Potential Acquisition of Vestis for Growth
- Understanding the Disclosure of Interests by Rathbones Group Plc
- Understanding Keywords Studios' Recent Disclosure Updates
- Insights on Shareholding and Market Activity of Rightmove Plc